M Orság

4-Arylazo-3,5-diamino-1<i>H</i>-pyrazole CDK Inhibitors:  SAR Study, Crystal Structure in Complex with CDK2, Selectivity, and Cellular Effects

Vladimı́r Kryštof, Petr Cankař, Iveta Fryšová et al. · Journal of Medicinal Chemistry · 2006 · 193 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Antiproliferative activity of olomoucine II, a novel 2,6,9-trisubstituted purine cyclin-dependent kinase inhibitor

Vladimı́r Kryštof, I.W. McNae, Malcolm D. Walkinshaw et al. · Cellular and Molecular Life Sciences · 2005 · 55 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

8-Azapurines as new inhibitors of cyclin-dependent kinases

Libor Havlı́ček, K. Fuksová, Vladimı́r Kryštof et al. · Bioorganic & Medicinal Chemistry · 2005 · 46 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

Analysis of 1119 burn injuries treated at the Bratislava Burn Department during a five-year period.

Ján Koller, M Orság, Elena Ondriašová et al. · PubMed · 1994 · 14 citations

Public Health, Pediatrics, Burn Surgery +10

Our experience with the use of cerium sulphadiazine in the treatment of extensive burns.

Ján Koller, M Orság · PubMed · 1998 · 14 citations

Medicine, Plastic Surgery, Surgery +15